| | |||||||
| lung cancer | |||||||
| 新闻 | |||||||
| |||||||
| JIN-A02, a Mutant-Selective Fourth-Generation EGFR inhibitor, Overcomes C797S ... Purpose: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the treatment of non–small cell lung cancer ...
| |||||||
| Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC The registrational TACTI-004 trial in first line non-small cell lung cancer (1L NSCLC) has enrolled 378 patients globally, 50% of the trial's ...
| |||||||
| Cancer Immunology Research's New Editors-in-Chief | Blog | AACR Elizabeth M. Jaffee and Antoni Ribas will showcase the next wave of immuno-oncology advances as Cancer Immunology Research's editors-in-chief.
| |||||||
| Repurposing Statins for Triple-Negative Breast Cancer Lung Cancer · Skin Cancer · Other Tumor Types · News · Treatment. Menu Main Logo ... These effects were seen not only in the main tumor cells but also ...
| |||||||
| Scientists now know why ovarian cancer spreads so rapidly in the abdomen Breast cancer or lung cancer cells enter blood vessels. They travel through the bloodstream to reach distant organs. Doctors can sometimes track these ...
| |||||||
Investigating New Therapies for High-Risk Therapy-Related MDS | Targeted Oncology This occurs in patients who previously received treatment—such as chemotherapy or radiation—for other cancers like breast cancer, lung cancer, or ...
| |||||||
| 查看更多结果 | 修改此快讯 | |||||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment